|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.01 USD | -0.15% |
|
-1.55% | +2.64% |
| Dec. 03 | Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM | |
| Dec. 02 | Qiagen N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11:15 AM |
Business description: Qiagen N.V.
Number of employees: 5,700
Sales by Activity: Qiagen N.V.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Medical Products | 1.87B | 2.25B | 2.14B | 1.97B | 1.98B |
Geographical breakdown of sales: Qiagen N.V.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
United States | 729M | 910M | 910M | 935M | 942M |
Europe, Middle East and Africa | 682M | 814M | 733M | 625M | 648M |
Asia Pacific, Japan and Rest of World | 363M | 430M | 410M | 321M | 298M |
Other Americas | 96.88M | 97.69M | 88.14M | 84.77M | 89.56M |
Executive Committee: Qiagen N.V.
| Manager | Title | Age | Since |
|---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 2019-10-06 |
Roland Sackers
DFI | Director of Finance/CFO | 57 | 2003-12-31 |
Antonio Santos
COO | Chief Operating Officer | - | 2022-03-31 |
Philipp von Hugo
CMP | Compliance Officer | 58 | 2003-11-30 |
Lezette Young
CMP | Compliance Officer | - | - |
Composition of the Board of Directors: Qiagen N.V.
| Director | Title | Age | Since |
|---|---|---|---|
Metin Colpan
BRD | Director/Board Member | 70 | 2003-12-31 |
| Director/Board Member | 76 | 2011-05-31 | |
Ross Levine
BRD | Director/Board Member | 53 | 2015-12-31 |
Toralf Haag
BRD | Director/Board Member | 59 | 2021-01-07 |
Eva Pisa
BRD | Director/Board Member | 71 | 2022-06-22 |
| Chairman | 67 | 2025-06-25 | |
Eva van Pelt
BRD | Director/Board Member | 60 | 2024-02-29 |
Bert van Meurs
BRD | Director/Board Member | 64 | 2024-03-31 |
Company details: Qiagen N.V.
Group companies: Qiagen N.V.
| Name | Category and Sector |
|---|---|
Qiagen Hamburg GmbH
 Qiagen Hamburg GmbH Medical/Nursing ServicesHealth Services Provides healthcare services |
Medical/Nursing Services
|
Chemicals: Specialty
| |
Chemicals: Specialty
| |
QIAGEN India Pvt Ltd. | |
QIAGEN India Pvt Ltd. |
Other Biotechnology & Medical Research
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | -1.55% | +5.24% | -9.86% | 10.19B | |
| -0.95% | -1.24% | +4.46% | +9.05% | 47.37B | |
| +0.41% | -1.81% | +12.96% | +6.57% | 38.46B | |
| -2.56% | -5.20% | +60.12% | +71.11% | 35.73B | |
| +0.38% | -1.24% | +10.59% | +19.98% | 27.23B | |
| +0.61% | -7.48% | +60.13% | +166.73% | 15.44B | |
| +1.48% | +2.42% | +68.37% | +227.47% | 15.4B | |
| +0.05% | +0.47% | -11.28% | -9.23% | 14.19B | |
| +0.43% | -1.63% | +44.21% | - | 13.64B | |
| -0.16% | -1.27% | +122.26% | +109.54% | 13.23B | |
| Average | -0.37% | -1.86% | +37.71% | +65.71% | 23.09B | |
| Weighted average by Cap. | -0.54% | -2.07% | +31.36% | +50.91% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QGEN Stock
- Company Qiagen N.V.
Select your edition
All financial news and data tailored to specific country editions
